Mandate

Vinge advises Concordia Bus in connection with new share issue and refinancing

September 08, 2009

Vinge has advised Concordia Bus in connection with the implementation of a rights issue subject to pre-emption rights for the existing shareholders and the exchange of the company’s existing senior notes in the amount of EUR 130 million for new senior notes. In connection with the rights issue, all of the company’s outstanding preference shares were redeemed. The new issue will generate just over SEK 800 million for the company.

Concordia Bus is one of Europe’s ten largest public transportation groups and the Nordic region’s leading bus transportation group. The group has approximately 7,000 employees and a turnover of approximately SEK 5.5 billion.

The Vinge team consisted of Ola Sandersson, Maria-Pia Midenbäck Hope, Bo Adrianzon, Mattias Schömer, Maria Doeser, Dain Nevonen, Nils-Taro Lock, Elin Hjort and Christian Granqvist.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026